Macdonald Henderson Solicitors

You are in: HomeNews › Macdonald Henderson Advises on Sale of RUA Medical to Aortech International – 11th March 2020

Macdonald Henderson Advises on Sale of RUA Medical to Aortech International – 11th March 2020 - Click for larger version Macdonald Henderson Advises on Sale of RUA Medical to Aortech International – 11th March 2020

Macdonald Henderson has advised the sole shareholder of RUA Medical Devices in the conditional agreed takeover by artificial heart valve developer AorTech International, in a £2.45 million deal which brings together two world-leading Scottish life sciences companies.

The businesses are both pioneers in creating materials and devices suitable for implanting in the human body during operations with life-saving potential.

Dundee-based Aortech is behind Elast-Eon, biostable polymer from which heart valves can be built. RUA, based in Irvine, creates implantable textiles which has dozens of applications including cardiovascular tubes, incontinence systems, spinal disc replacements and mesh to repair hernia and organ prolapse.

RUA founder David Richmond, who is already a non-executive director of Aortech and sole shareholder of RUA, will become group chief executive.

The expanded firm will be known as RUA Life Sciences plc.

AorTech chairman Bill Brown: "This deal is a perfect strategic fit for the company providing the people, processes and premises to allow our world class polymers to be converted into medical device products. We look forward to a closer working relationship with David Richmond and his talented team at RUA and are delighted that David has demonstrated his belief and confidence in the prospects for all of our Elast-Eon enabled devices by taking a substantial interest in the company."

The deal which values RUA at £2.45 million will involve £950,000 in cash with the rest in the form of 1,500,000 new Ordinary Shares at £1 each.
Aortech was founded in Lanarkshire in 2005 but is now based in Dundee's Technology Park.

Walker Crips Stockbrokers is its largest shareholder at 21%. Last year Aortech reported revenue of £299,000. Utah firm Biomerics is licensed to build devices with Elas-Eon in the US.

RUA founder Mr Richmond is from the family behind lace-making firm Flemings Laces, which dates back to 1881.

David set up the medical textiles business in 2004 and it has a turnover of around £1.6 million. It has its HQ in Irvine and premises in Prestwick.

Laura McKnight, David Beveridge and Ian Anderson of Macdonald Henderson advised the shareholder of RUA Medical on the deal, with Iain D Sim + Co advising on accountancy and tax.

[with acknowledgement of copy from Scottish Business Insider]

Last updated: 11.58am, Wednesday 11th March 2020

Latest News and Events

We are delighted to share an article by our colleague Laura McKnight (director) who has taken some time out from her busy corporate transactional role, to consider the post Covid M&A/investment deal market and highlight some key features to look out for.
Macdonald Henderson has advised fast growing medical device company Emblation, on an eight figure investment by healthcare investor Apposite Capital to support its international growth and broaden its go-to market offering.

Meet the Team at Macdonald Henderson